Targeting the inflammatory response in tuberculosis

New England Journal of Medicine

Volumn 371, Issue 14, 2014, Pages 1354-1356

  Friedland, Jon S ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; C REACTIVE PROTEIN; ICOSANOID; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; PROSTAGLANDIN E2; INTERFERON;

ARTICLE; BACTERIAL GROWTH; BACTERIAL LOAD; CYTOKINE RELEASE; CYTOKINE RESPONSE; HUMAN; INNATE IMMUNITY; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; PROTEIN TARGETING; TUBERCULOSIS; ANIMAL; BIOSYNTHESIS; DISEASE MODEL; DRUG ANTAGONISM; GROWTH, DEVELOPMENT AND AGING; IMMUNOLOGY; IMMUNOTHERAPY; LUNG TUBERCULOSIS; METABOLISM; MOUSE;

ANIMALS; DINOPROSTONE; DISEASE MODELS, ANIMAL; EICOSANOIDS; HUMANS; IMMUNOTHERAPY; INTERFERON TYPE I; INTERLEUKIN-1; MICE; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS, PULMONARY;

EID: 84907755911     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMcibr1408663     Document Type: Article

References (1)

1. Mayer-Barber KD, Andrade BB, Oland SD, er al. Host-directed therapy of tuberculosis based on interleukin-1 and type I interferon crosstalk. Nature 2014;511:99-103.